FDA Approves Novo Nordisk’s Saxenda as a Treatment for Chronic Weight Management
Saxenda is a once-daily compacted GLP-1 agonist which will arrive in a pencil offering around your 3.0 ounce dose. As background, the medication’s active ingredient, liraglutide, is currently available at the type two diabetes medication Victoza in an optimum dose of 1.8 mg. While Victoza induces a little weight reduction in many individuals, the bigger ...